The use of Epstein-Barr virus transformation for the establishment of class II positive cord blood cells for use in analysis of maternal sera.
The use of Epstein-Barr virus transformed cord blood cells to detect maternal antibodies to neonatal class II DR and DQ antigens and to allotype the reacting cells is described.
D000956:Antigens, Viral / Q000032:analysis; D002213:Capsid / Q000276:immunology; D002472:Cell Transformation, Viral; D005312:Fetal Blood / Q000166:cytology* / Q000276:immunology; D006684:HLA-DR Antigens; D004854:Herpesvirus 4, Human / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D006650:Histocompatibility Testing / Q000379:methods; D006801:Humans
D000956:Antigens, Viral; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II